JUST FOR FUN
But why pic.twitter.com/C0AGQcRStQ— Science girl (@gunsnrosesgirl3) January 12, 2025
But why pic.twitter.com/C0AGQcRStQ
The name change arrives with Novo shares down 15% in 2026, despite the propitious launch of the oral version of its obesity drug Wegovy.
Anthropic’s S-1 filing with the SEC is expected to be released publicly in the coming days or weeks, and it will likely face new scrutiny.
Older investors tend to be more cautious, according to a Northwestern Mutual study.
The three firms now manage 52% of assets among the largest 150 fund companies, up from 43% a decade ago.
Research Affiliates, which recently sold its RAFI Indices business to TMX, just had a major brand overhaul.
All signs point to an interest-rate hike when the Federal Reserve’s monetary policy concludes this week’s meeting.
